Drugs / VDO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02207881 | Jul 2014 → Dec 2015 | herpes labialis | Yung Shin Pharm. Ind. Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VDO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02207881 ↗ |
| Route | Topical | “a topical formulation of VDO” NCT02207881 ↗ |